FDA Cosmetics Update: 2013 AE Reports Tallied, 2014 Research Targeted
This article was originally published in The Rose Sheet
Executive Summary
FDA says cosmetic-related adverse events were down in fiscal 2013, but suggests the decline may be due to a falloff in agency outreach and lower consumer awareness. The agency is focused on trace contaminants, with guidance in the works on lipstick lead, and aims to release its final guidance on cosmetic nanomaterials in the coming months, according to Linda Katz, director of FDA’s cosmetics office.